The Danish pharmaceutical firm requires to relocate at a quicker rate if it is to take on Roche’s hit Hemlibra for more youthful people with hemophilia. However Novo Nordisk has one benefit.
发布者:BY IDA JORGENSEN,转转请注明出处:https://robotalks.cn/novo-nordisk-struggles-in-hemophilia-competition-with-roche-2/